Page last updated: 2024-11-08

serine and ALS - Amyotrophic Lateral Sclerosis

serine has been researched along with ALS - Amyotrophic Lateral Sclerosis in 48 studies

Serine: A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from GLYCINE or THREONINE. It is involved in the biosynthesis of PURINES; PYRIMIDINES; and other amino acids.
serine : An alpha-amino acid that is alanine substituted at position 3 by a hydroxy group.

Research Excerpts

ExcerptRelevanceReference
"Impaired enzymatic activity in D-amino acid oxidase (DAAO) caused by missense mutations has been shown to trigger amyotrophic lateral sclerosis (ALS) through an abnormal accumulation of D-serine in the spinal cord."3.96Mechanistic insights into the loss-of-function mechanisms of rare human D-amino acid oxidase variants implicated in amyotrophic lateral sclerosis. ( Padhi, AK; Zhang, KYJ, 2020)
"The substitution of Proline with Serine at residue 56 (P56S) of vesicle-associated membrane protein-associated protein B (VAPB) has been linked to an atypical autosomal dominant form of familial amyotrophic lateral sclerosis 8 (ALS8)."3.79Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons. ( Aliaga, L; Cai, H; Chub, N; Lai, C; Lin, X; O'Donovan, MJ; Shim, H; Sun, L; Xie, C; Yang, WJ; Yu, J, 2013)
"Hydroxyl radical, ascorbate free radical, superoxide dismutase (SOD) activities, Cu,Zn-SOD protein, Mn-SOD protein, 8-hydroxy-2' -deoxyguanosine (8-OHdG) and metals were compared in red blood cells (RBC), plasma and/or cerebrospinal fluid (CSF) between patients with sporadic amyotrophic lateral sclerosis (SALS), familial ALS (FALS) showing the Leu126Ser mutation in the Cu, Zn-SOD gene and controls."3.73Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation. ( Hayabara, T; Ihara, Y; Nobukuni, K; Takata, H, 2005)
" Based on this small study, L-serine appears to be generally safe for patients with ALS."2.84Phase I clinical trial of safety of L-serine for ALS patients. ( Banack, SA; Bradley, WG; Cox, PA; Flynn, LE; Forshew, DA; Katz, JS; Levine, TD; Metcalf, JS; Miller, RG; Moore, DH; Saperstein, DS, 2017)
" Hyperphosphorylated TDP-43 was found within the inclusion bodies in disease lesions; however, the role of hyperphosphorylation and the toxic species are still ambiguous."1.72Hyperphosphorylation-Mimetic TDP-43 Drives Amyloid Formation and Possesses Neuronal Toxicity at the Oligomeric Stage. ( Chang, LY; Chen, YR; Chiang, WC; Chou, SC; Fang, YS; Ganesan, K; Huang, SH; Lye, YS; Weng, TY, 2022)
" UHPLC-MS/MS was used to confirm BMAA exposures in dosed vervets."1.56l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND. ( Banack, SA; Beierschmitt, A; Bradley, WG; Cox, PA; Davis, DA; Garamszegi, SP; Hagan, MJ; Lecusay, PD; Mash, DC; Metcalf, JS; Palmour, RM; Powell, JT, 2020)
"Amyotrophic lateral sclerosis (ALS) is a devastating disease characterized by upper and lower motor neuron damage."1.36Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease. ( Hirayama, T; Ikeda, K; Ito, H; Iwasaki, Y; Kano, O; Kawabe, K; Nakamura, Y; Sobue, G; Takazawa, T; Tanaka, F; Yoshii, Y, 2010)

Research

Studies (48)

TimeframeStudies, this research(%)All Research%
pre-19902 (4.17)18.7374
1990's2 (4.17)18.2507
2000's16 (33.33)29.6817
2010's22 (45.83)24.3611
2020's6 (12.50)2.80

Authors

AuthorsStudies
Lone, MA1
Aaltonen, MJ1
Zidell, A1
Pedro, HF1
Morales Saute, JA1
Mathew, S1
Mohassel, P1
Bönnemann, CG1
Shoubridge, EA1
Hornemann, T1
Chiang, WC1
Fang, YS1
Lye, YS1
Weng, TY1
Ganesan, K1
Huang, SH1
Chang, LY1
Chou, SC1
Chen, YR1
Di Maio, A1
Nuzzo, T1
Gilio, L1
Serra, M1
Buttari, F1
Errico, F1
De Rosa, A1
Bassi, MS1
Morelli, M1
Sasabe, J5
Sulzer, D1
Carta, M1
Centonze, D1
Usiello, A1
Ye, J1
Cheung, J1
Gerbino, V1
Ahlsén, G1
Zimanyi, C1
Hirsh, D1
Maniatis, T1
Davis, DA2
Cox, PA4
Banack, SA3
Lecusay, PD1
Garamszegi, SP1
Hagan, MJ1
Powell, JT1
Metcalf, JS3
Palmour, RM1
Beierschmitt, A1
Bradley, WG3
Mash, DC2
Chen, Q1
Konrad, C1
Sandhu, D1
Roychoudhury, D1
Schwartz, BI1
Cheng, RR1
Bredvik, K1
Kawamata, H1
Calder, EL1
Studer, L1
Fischer, SM1
Manfredi, G1
Gross, SS1
Padhi, AK1
Zhang, KYJ1
Miller, RX1
Levine, TD2
Stommel, EW1
Aliaga, L1
Lai, C1
Yu, J1
Chub, N1
Shim, H1
Sun, L1
Xie, C1
Yang, WJ1
Lin, X1
O'Donovan, MJ1
Cai, H1
Paul, P3
Murphy, T1
Oseni, Z1
Sivalokanathan, S1
de Belleroche, JS1
Bardaweel, SK1
Alzweiri, M1
Ishaqat, AA1
de Belleroche, J2
Abdelkarim, S1
Morgan, S1
Plagnol, V1
Lu, CH1
Adamson, G1
Howard, R1
Malaspina, A1
Orrell, R1
Sharma, N1
Sidle, K1
Clarke, J1
Fox, NC1
Rossor, MN1
Warren, JD1
Clark, CN1
Rohrer, JD1
Fisher, EM1
Mead, S1
Pittman, A1
Fratta, P1
Brenner, D1
Müller, K1
Wieland, T1
Weydt, P1
Böhm, S1
Lulé, D1
Hübers, A1
Neuwirth, C1
Weber, M1
Borck, G1
Wahlqvist, M1
Danzer, KM1
Volk, AE1
Meitinger, T1
Strom, TM1
Otto, M1
Kassubek, J1
Ludolph, AC1
Andersen, PM1
Weishaupt, JH1
Miller, RG1
Moore, DH1
Saperstein, DS1
Flynn, LE1
Katz, JS1
Forshew, DA1
Lin, H1
Hu, H1
Duan, W1
Liu, Y2
Tan, G1
Li, Z1
Deng, B1
Song, X1
Wang, W1
Wen, D1
Wang, Y1
Li, C1
Inukai, Y1
Nonaka, T2
Arai, T2
Yoshida, M1
Hashizume, Y1
Beach, TG1
Buratti, E1
Baralle, FE1
Akiyama, H3
Hisanaga, S1
Hasegawa, M2
Kametani, F1
Suzuki, T1
Dohmae, N1
Kadoyama, K1
Funakoshi, H1
Ohya-Shimada, W1
Nakamura, T2
Matsumoto, K1
Matsuyama, S1
Takazawa, T1
Ikeda, K1
Hirayama, T1
Kawabe, K1
Nakamura, Y1
Ito, H2
Kano, O1
Yoshii, Y1
Tanaka, F1
Sobue, G1
Iwasaki, Y1
Nozaki, I1
Arai, M1
Takahashi, K1
Hamaguchi, T1
Yoshikawa, H1
Muroishi, T1
Noguchi-Shinohara, M1
Itokawa, M1
Kawata, A1
Yamada, M2
Aiso, S5
Brotherton, T1
Polak, M1
Kelly, C1
Birve, A1
Andersen, P1
Marklund, SL1
Glass, JD1
Subramony, SH1
Ashizawa, T1
Langford, L1
McKenna, R1
Avvaru, B1
Siddique, T1
Vedanarayanan, V1
Thompson, M1
Marecki, JC1
Marinesco, S1
Labrie, V1
Roder, JC1
Barger, SW1
Crow, JP1
Miyoshi, Y2
Suzuki, M2
Mita, M1
Konno, R2
Matsuoka, M3
Hamase, K2
Yamanaka, M1
Ohide, H1
Satoi, H1
Tomimoto, H1
Ohtani, R1
Kitano, T1
Kondo, T1
Watanabe, M1
Oka, N1
Akiguchi, I1
Furuya, S1
Hirabayashi, Y1
Okazaki, T1
Battistini, S1
Giannini, F1
Greco, G1
Bibbò, G1
Ferrera, L1
Marini, V1
Causarano, R1
Casula, M1
Lando, G1
Patrosso, MC1
Caponnetto, C1
Origone, P1
Marocchi, A1
Del Corona, A1
Siciliano, G2
Carrera, P1
Mascia, V1
Giagheddu, M1
Carcassi, C1
Orrù, S1
Garrè, C1
Penco, S1
Ihara, Y1
Nobukuni, K1
Takata, H1
Hayabara, T1
Slowik, A1
Tomik, B1
Wolkow, PP1
Partyka, D1
Turaj, W1
Malecki, MT1
Pera, J1
Dziedzic, T1
Szczudlik, A1
Figlewicz, DA1
Kanekura, K1
Nishimoto, I2
Watanabe, S1
Nagano, S1
Duce, J1
Kiaei, M1
Li, QX1
Tucker, SM1
Tiwari, A1
Brown, RH1
Beal, MF1
Hayward, LJ1
Culotta, VC1
Yoshihara, S1
Sakoda, S1
Bush, AI1
Lobsiger, CS1
Boillée, S1
Cleveland, DW1
Coppedè, F1
Mancuso, M1
Lo Gerfo, A1
Carlesi, C1
Piazza, S1
Rocchi, A1
Petrozzi, L1
Nesti, C1
Micheli, D1
Bacci, A1
Migliore, L1
Murri, L1
Mitne-Neto, M1
Ramos, CR1
Pimenta, DC1
Luz, JS1
Nishimura, AL1
Gonzales, FA1
Oliveira, CC1
Zatz, M1
Morimoto, N1
Nagai, M1
Ohta, Y1
Miyazaki, K1
Kurata, T1
Morimoto, M1
Murakami, T1
Takehisa, Y1
Ikeda, Y1
Kamiya, T1
Abe, K1
Chiba, T1
Okamoto, K1
Irie, T1
Watanabe, T1
Mikami, H1
Yamazaki, T1
Oyanagi, K1
Ono, S1
Van Deerlin, VM1
Leverenz, JB1
Bekris, LM1
Bird, TD1
Yuan, W1
Elman, LB1
Clay, D1
Wood, EM1
Chen-Plotkin, AS1
Martinez-Lage, M1
Steinbart, E1
McCluskey, L1
Grossman, M1
Neumann, M1
Wu, IL1
Yang, WS1
Kalb, R1
Galasko, DR1
Montine, TJ1
Trojanowski, JQ2
Lee, VM2
Schellenberg, GD1
Yu, CE1
Rainero, I1
Pinessi, L1
Tsuda, T1
Vignocchi, MG1
Vaula, G1
Calvi, L1
Cerrato, P1
Rossi, B1
Bergamini, L1
McLachlan, DR1
Mawal-Dewan, M1
Schmidt, ML1
Balin, B1
Perl, DP1
Katunuma, N1
Yasogawa, N1
Kito, K1
Sanada, Y1
Kawai, H1
Miyoshi, K1
Pivovarova, VM1

Clinical Trials (3)

Trial Overview

TrialPhaseEnrollmentStudy TypeStart DateStatus
Tolerability and Efficacy of L-Serine in Patients With Amyotrophic Lateral Sclerosis: A Phase IIa Study[NCT03580616]Phase 243 participants (Actual)Interventional2018-10-24Terminated (stopped due to Study was terminated by the IRB due to continued noncompliance.)
Identification of Genes Causing Familial ALS or Increasing Risk for Sporadic ALS and ALS With Frontotemporal Dementia and Understanding Disease Mechanism.[NCT00821132]13,521 participants (Actual)Observational1991-01-31Completed
Amyotrophic Lateral Sclerosis and the Innate Immune System[NCT02869048]375 participants (Anticipated)Observational2016-06-30Recruiting
[information is prepared from clinicaltrials.gov, extracted Sep-2024]

Reviews

6 reviews available for serine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
D-Serine in neurobiology: CNS neurotransmission and neuromodulation.
    The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques, 2014, Volume: 41, Issue:2

    Topics: Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Central Nervous System; Epilepsy; Glutami

2014
Experimental approaches for elucidating co-agonist regulation of NMDA receptor in motor neurons: Therapeutic implications for amyotrophic lateral sclerosis (ALS).
    Journal of pharmaceutical and biomedical analysis, 2015, Dec-10, Volume: 116

    Topics: Amyotrophic Lateral Sclerosis; Animals; D-Amino-Acid Oxidase; Excitatory Amino Acid Agonists; Humans

2015
Aberrant control of motoneuronal excitability in amyotrophic lateral sclerosis: excitatory glutamate/D-serine vs. inhibitory glycine/gamma-aminobutanoic acid (GABA).
    Chemistry & biodiversity, 2010, Volume: 7, Issue:6

    Topics: Amyotrophic Lateral Sclerosis; Excitatory Amino Acids; gamma-Aminobutyric Acid; Glutamic Acid; Glyci

2010
[D-serine in the pathogenesis of amyotrophic lateral sclerosis].
    Seikagaku. The Journal of Japanese Biochemical Society, 2010, Volume: 82, Issue:7

    Topics: Amyotrophic Lateral Sclerosis; Animals; Cell Death; Humans; Mice; Neurons; Receptors, N-Methyl-D-Asp

2010
The role of D-amino acids in amyotrophic lateral sclerosis pathogenesis: a review.
    Amino acids, 2012, Volume: 43, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Animals; Brain; D-Amino-Acid Oxidase; Disease Progression; Gene Expre

2012
D-Amino acids in the brain and mutant rodents lacking D-amino-acid oxidase activity.
    Amino acids, 2012, Volume: 43, Issue:5

    Topics: Amyotrophic Lateral Sclerosis; Animals; Behavior, Animal; Brain; D-Amino-Acid Oxidase; D-Aspartic Ac

2012

Trials

2 trials available for serine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
Studies of Environmental Risk Factors in Amyotrophic Lateral Sclerosis (ALS) and a Phase I Clinical Trial of L-Serine.
    Neurotoxicity research, 2018, Volume: 33, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Environmental Exposure; Female; Humans; Male; Middle Aged; Neuroprote

2018
Phase I clinical trial of safety of L-serine for ALS patients.
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2017, Volume: 18, Issue:1-2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Disease Progression; Dose

2017

Other Studies

40 other studies available for serine and ALS - Amyotrophic Lateral Sclerosis

ArticleYear
SPTLC1 variants associated with ALS produce distinct sphingolipid signatures through impaired interaction with ORMDL proteins.
    The Journal of clinical investigation, 2022, 09-15, Volume: 132, Issue:18

    Topics: Amyotrophic Lateral Sclerosis; Hereditary Sensory and Autonomic Neuropathies; Humans; Membrane Prote

2022
Hyperphosphorylation-Mimetic TDP-43 Drives Amyloid Formation and Possesses Neuronal Toxicity at the Oligomeric Stage.
    ACS chemical neuroscience, 2022, 09-07, Volume: 13, Issue:17

    Topics: Amyloid; Amyloidogenic Proteins; Amyloidosis; Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; H

2022
Homeostasis of serine enantiomers is disrupted in the post-mortem caudate putamen and cerebrospinal fluid of living Parkinson's disease patients.
    Neurobiology of disease, 2023, Volume: 184

    Topics: Alzheimer Disease; Amino Acids; Amyotrophic Lateral Sclerosis; Homeostasis; Humans; N-Methylaspartat

2023
Effects of ALS-associated TANK binding kinase 1 mutations on protein-protein interactions and kinase activity.
    Proceedings of the National Academy of Sciences of the United States of America, 2019, 12-03, Volume: 116, Issue:49

    Topics: Amyotrophic Lateral Sclerosis; Cell Cycle Proteins; Enzyme Activation; Humans; Membrane Transport Pr

2019
l-Serine Reduces Spinal Cord Pathology in a Vervet Model of Preclinical ALS/MND.
    Journal of neuropathology and experimental neurology, 2020, 04-01, Volume: 79, Issue:4

    Topics: Amino Acids, Diamino; Amyotrophic Lateral Sclerosis; Animals; Chlorocebus aethiops; Cyanobacteria To

2020
Accelerated transsulfuration metabolically defines a discrete subclass of amyotrophic lateral sclerosis patients.
    Neurobiology of disease, 2020, Volume: 144

    Topics: Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Cells, Cultured; Cysteine; Female; Fibrob

2020
Mechanistic insights into the loss-of-function mechanisms of rare human D-amino acid oxidase variants implicated in amyotrophic lateral sclerosis.
    Scientific reports, 2020, 10-13, Volume: 10, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Crystallography, X-Ray; D-Amino-Acid Oxidase; Flavin-Adenine Dinucleo

2020
Amyotrophic lateral sclerosis-related VAPB P56S mutation differentially affects the function and survival of corticospinal and spinal motor neurons.
    Human molecular genetics, 2013, Nov-01, Volume: 22, Issue:21

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell Survival; Dendrites; Humans; M

2013
Pathogenic effects of amyotrophic lateral sclerosis-linked mutation in D-amino acid oxidase are mediated by D-serine.
    Neurobiology of aging, 2014, Volume: 35, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Astrocytes; Autophagy; Cells, Cultured; D-Amino-A

2014
CHCHD10 Pro34Ser is not a highly penetrant pathogenic variant for amyotrophic lateral sclerosis and frontotemporal dementia.
    Brain : a journal of neurology, 2016, Volume: 139, Issue:Pt 2

    Topics: Amyotrophic Lateral Sclerosis; Cohort Studies; Frontotemporal Dementia; Genetic Variation; Humans; M

2016
Dietary exposure to an environmental toxin triggers neurofibrillary tangles and amyloid deposits in the brain.
    Proceedings. Biological sciences, 2016, Jan-27, Volume: 283, Issue:1823

    Topics: Amino Acids, Diamino; Amyloid beta-Peptides; Amyotrophic Lateral Sclerosis; Animals; Brain; Chloroce

2016
NEK1 mutations in familial amyotrophic lateral sclerosis.
    Brain : a journal of neurology, 2016, Volume: 139, Issue:Pt 5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Brain; Cohort Studies; Family Health; Female; Gene Frequ

2016
ALSUntangled 38: L-serine.
    Amyotrophic lateral sclerosis & frontotemporal degeneration, 2017, Volume: 18, Issue:1-2

    Topics: Amyotrophic Lateral Sclerosis; Clinical Trials as Topic; Humans; Risk; Serine; Treatment Outcome

2017
Intramuscular Delivery of scAAV9-hIGF1 Prolongs Survival in the hSOD1
    Molecular neurobiology, 2018, Volume: 55, Issue:1

    Topics: Amyotrophic Lateral Sclerosis; Animals; Apoptosis; D-Amino-Acid Oxidase; Dependovirus; Disease Model

2018
Abnormal phosphorylation of Ser409/410 of TDP-43 in FTLD-U and ALS.
    FEBS letters, 2008, Aug-20, Volume: 582, Issue:19

    Topics: Amyotrophic Lateral Sclerosis; Animals; Antibodies, Monoclonal; Brain; Dementia; DNA-Binding Protein

2008
Identification of casein kinase-1 phosphorylation sites on TDP-43.
    Biochemical and biophysical research communications, 2009, May-01, Volume: 382, Issue:2

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Brain; Casein Kinase I; Dementia; DNA-Binding Pr

2009
Disease-dependent reciprocal phosphorylation of serine and tyrosine residues of c-Met/HGF receptor contributes disease retardation of a transgenic mouse model of ALS.
    Neuroscience research, 2009, Volume: 65, Issue:2

    Topics: Amino Acid Sequence; Amyotrophic Lateral Sclerosis; Animals; Catalytic Domain; Central Nervous Syste

2009
Familial amyotrophic lateral sclerosis with a novel G85S mutation of superoxide dismutase 1 gene: clinical features of lower motor neuron disease.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:2

    Topics: Adult; Amyotrophic Lateral Sclerosis; Fatal Outcome; Female; Glycine; Humans; Male; Motor Neuron Dis

2010
Familial ALS with G298S mutation in TARDBP: a comparison of CSF tau protein levels with those in sporadic ALS.
    Internal medicine (Tokyo, Japan), 2010, Volume: 49, Issue:12

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; DNA-Binding Proteins; Glycine; Humans; Male;

2010
A novel ALS SOD1 C6S mutation with implications for aggregation related toxicity and genetic counseling.
    Amyotrophic lateral sclerosis : official publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2011, Volume: 12, Issue:3

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Cysteine; Disulfides; DNA Mutational Analysis; Female; G

2011
Confirmation of the severe phenotypic effect of serine at codon 41 of the superoxide dismutase 1 gene.
    Muscle & nerve, 2011, Volume: 44, Issue:4

    Topics: Adult; Amyotrophic Lateral Sclerosis; Family Health; Female; Glycine; Humans; Male; Middle Aged; Mod

2011
Paradoxical roles of serine racemase and D-serine in the G93A mSOD1 mouse model of amyotrophic lateral sclerosis.
    Journal of neurochemistry, 2012, Volume: 120, Issue:4

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Disease Progression; Female; Humans;

2012
D-amino acid oxidase controls motoneuron degeneration through D-serine.
    Proceedings of the National Academy of Sciences of the United States of America, 2012, Jan-10, Volume: 109, Issue:2

    Topics: Amyotrophic Lateral Sclerosis; Animals; Astrocytes; Blotting, Western; Cell Death; Chromatography, H

2012
Astroglial expression of ceramide in Alzheimer's disease brains: a role during neuronal apoptosis.
    Neuroscience, 2005, Volume: 130, Issue:3

    Topics: Aged; Alzheimer Disease; Amyotrophic Lateral Sclerosis; Animals; Apoptosis; Astrocytes; Cell Line, T

2005
SOD1 mutations in amyotrophic lateral sclerosis. Results from a multicenter Italian study.
    Journal of neurology, 2005, Volume: 252, Issue:7

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Amyotrophic Lateral Sclerosis; Blotting, Northern; Cohor

2005
Oxidative stress and metal content in blood and cerebrospinal fluid of amyotrophic lateral sclerosis patients with and without a Cu, Zn-superoxide dismutase mutation.
    Neurological research, 2005, Volume: 27, Issue:1

    Topics: 8-Hydroxy-2'-Deoxyguanosine; Aged; Amyotrophic Lateral Sclerosis; Case-Control Studies; Deoxyguanosi

2005
Paraoxonase gene polymorphisms and sporadic ALS.
    Neurology, 2006, Sep-12, Volume: 67, Issue:5

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Arginine; Aryldialkylphosphatase; Chi-Square Distributio

2006
Characterization of amyotrophic lateral sclerosis-linked P56S mutation of vesicle-associated membrane protein-associated protein B (VAPB/ALS8).
    The Journal of biological chemistry, 2006, Oct-06, Volume: 281, Issue:40

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Cell Line, Tumor; Endoplasmic Retic

2006
Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
    Free radical biology & medicine, 2007, May-15, Volume: 42, Issue:10

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Animals; Chlorocebus aethiops; Chromatograph

2007
Toxicity from different SOD1 mutants dysregulates the complement system and the neuronal regenerative response in ALS motor neurons.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, May-01, Volume: 104, Issue:18

    Topics: Aging; Amyotrophic Lateral Sclerosis; Animals; Animals, Genetically Modified; Cell Separation; Enzym

2007
Association of the hOGG1 Ser326Cys polymorphism with sporadic amyotrophic lateral sclerosis.
    Neuroscience letters, 2007, Jun-13, Volume: 420, Issue:2

    Topics: Age Factors; Aged; Amino Acid Sequence; Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cyst

2007
A mutation in human VAP-B--MSP domain, present in ALS patients, affects the interaction with other cellular proteins.
    Protein expression and purification, 2007, Volume: 55, Issue:1

    Topics: Amino Acid Substitution; Amyotrophic Lateral Sclerosis; Cloning, Molecular; Escherichia coli; Glycer

2007
Increased autophagy in transgenic mice with a G93A mutant SOD1 gene.
    Brain research, 2007, Sep-05, Volume: 1167

    Topics: Amyotrophic Lateral Sclerosis; Animals; Autophagy; Central Nervous System; Disease Models, Animal; F

2007
D-serine is a key determinant of glutamate toxicity in amyotrophic lateral sclerosis.
    The EMBO journal, 2007, Sep-19, Volume: 26, Issue:18

    Topics: Amyotrophic Lateral Sclerosis; Animals; Disease Models, Animal; Enzyme Activation; Enzyme Induction;

2007
Familial amyotrophic lateral sclerosis with Gly93Ser mutation in Cu/Zn superoxide dismutase: a clinical and neuropathological study.
    Journal of the neurological sciences, 2008, May-15, Volume: 268, Issue:1-2

    Topics: Adult; Amyotrophic Lateral Sclerosis; Central Nervous System; Family Health; Female; Glycine; Humans

2008
TARDBP mutations in amyotrophic lateral sclerosis with TDP-43 neuropathology: a genetic and histopathological analysis.
    The Lancet. Neurology, 2008, Volume: 7, Issue:5

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Alanine; Amyotrophic Lateral Sclerosis; Brain; Child; De

2008
SOD1 missense mutation in an Italian family with ALS.
    Neurology, 1994, Volume: 44, Issue:2

    Topics: Adult; Amyotrophic Lateral Sclerosis; Base Sequence; Chromosomes, Human, Pair 21; DNA; DNA Primers;

1994
Identification of phosphorylation sites in PHF-TAU from patients with Guam amyotrophic lateral sclerosis/parkinsonism-dementia complex.
    Journal of neuropathology and experimental neurology, 1996, Volume: 55, Issue:10

    Topics: Aged; Amyotrophic Lateral Sclerosis; Binding Sites, Antibody; Blotting, Western; Brain Chemistry; De

1996
Abnormal expression of a serine protease in human dystrophic muscle.
    Journal of biochemistry, 1978, Volume: 83, Issue:2

    Topics: Adult; Aged; Amyotrophic Lateral Sclerosis; Child; Child, Preschool; Endopeptidases; Humans; L-Lacta

1978
[Amino acid metabolism in lateral amyotrophic sclerosis].
    Zhurnal nevropatologii i psikhiatrii imeni S.S. Korsakova (Moscow, Russia : 1952), 1971, Volume: 71, Issue:8

    Topics: Adult; Aged; Amino Acids; Amyotrophic Lateral Sclerosis; Arginine; Female; Humans; Leucine; Male; Mi

1971